...believe I have heard of drugs being approved in Europe before the FDA.
This is definitely true. A recent example is Glybera (Uniqure’s gene therapy for lipoprotein lipase deficiency) which was approved by the EMA, but not by the FDA, who wanted another Phase 3 trial doing.